Robot-assisted versus laparoscopic minimally invasive surgery for the treatment of stage I endometrial cancer.

Journal: Gynecologic oncology
PMID: 35314086

Abstract

OBJECTIVE: Recent reports in both cervical and endometrial cancer suggest that minimally invasive surgery (MIS) had an unanticipated negative impact on long-term clinical outcomes, including recurrence and death. Given increasing use of robotic surgery since the LAP2 trial, we sought to compare the intermediate and long-term outcomes between those who underwent robotic surgery or laparoscopy for Stage I endometrial cancer.

Authors

  • Peter A Argenta
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN, United States of America. Electronic address: argenta@umn.edu.
  • Jordan Mattson
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN, United States of America.
  • Colleen L Rivard
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN, United States of America.
  • Elizabeth Luther
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN, United States of America.
  • Alexandra Schefter
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN, United States of America.
  • Rachel I Vogel
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN, United States of America.

Keywords

External Resources

Popular Topics
Recent Journals